# Early phase 1 Autoimmune Diseases trials: 29 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 29 trials in early phase 1 for Autoimmune Diseases that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Early phase 1 Autoimmune Diseases trials: 29 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/early-phase-1/autoimmune-diseases

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 29
- Recruiting or not yet: 29
- Read on: November 19, 2026

## Trials

The 25 newest of 29, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| July 13, 2026 | NCT07697274 | Hyaluronidase for Sclerodactyly in Systemic Sclerosis Trial | Medical University of South Carolina | Early phase 1 | Not yet recruiting | Systemic Sclerosis, Sclerodactyly | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07697274) |
| June 29, 2026 | NCT07674147 | RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases | The Children's Hospital of Zhejiang University School of Medicine | Early phase 1 | Not yet recruiting | Autoimmune Diseases, SLE - Systemic Lupus Erythematosus, SSc-Systemic Sclerosis, IIM- Idiopathic Inflammatory... | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07674147) |
| June 5, 2026 | NCT07629596 | Evaluation of Safety, Pharmacokinetics and Pharmacodynamics of Arnovie101, an mRNA-LNP-Based In Vivo CAR-T Therapy, for the Treatment of B... | Circunited BioPharma (Shenzhen) Co., Ltd. | Early phase 1 | Recruiting | Systemic Lupus Erythematosus, Autoimmune Hemolytic Anemia (AIHA) | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07629596) |
| May 29, 2026 | NCT07613411 | Safety and Efficacy of KSVCBD Injection in Autoimmune Diseases | Chinese PLA General Hospital | Early phase 1 | Not yet recruiting | Autoimmune Diseases | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07613411) |
| May 14, 2026 | NCT07586267 | CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease | The Children's Hospital of Zhejiang University School of Medicine | Early phase 1 | Recruiting | Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07586267) |
| April 2, 2026 | NCT07507201 | Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease | The Children's Hospital of Zhejiang University School of Medicine | Early phase 1 | Recruiting | Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), Multi-Drug Resistant Nephrotic Syndrome, IgA Nephropathy... | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07507201) |
| February 13, 2026 | NCT07408336 | Clinical Study of AFN50 Injection in the Autoimmune Diseases | AlphaNa Bioscience Company Limited | Early phase 1 | Recruiting | Autoimmune Diseases | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07408336) |
| February 5, 2026 | NCT07388212 | Exploratory Study on LNP-mRNA Drugs Targeting CD19/BCMA for the Treatment of Relapsed and Refractory Autoimmune Diseases | West China Hospital | Early phase 1 | Not yet recruiting | Autoimmune Diseases | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07388212) |
| January 23, 2026 | NCT07362758 | Exploratory Study on mRNA Therapy Targeting CD19 for the Treatment of Refractory Autoimmune Diseases | Xinqiao Hospital of Chongqing | Early phase 1 | Not yet recruiting | Autoimmune Diseases | 47 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07362758) |
| January 20, 2026 | NCT07349823 | Exploratory Study on the Treatment of Relapsed and Refractory Immune Related Diseases With WGb-0301 Injection | West China Hospital | Early phase 1 | Not yet recruiting | Autoimmune Diseases | 47 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07349823) |
| January 7, 2026 | NCT07322718 | Safety and Efficacy Study of RXIM002 in Severe, Relapsed or Refractory Autoimmune Diseases | Ruijin Hospital | Early phase 1 | Recruiting | Relapsed/Refractory B Cell-Mediated Autoimmune Diseases | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322718) |
| December 15, 2025 | NCT07283315 | Exploratory Clinical Study of Second-generation CD19/BCMA Chimeric Antigen Receptor NK Cell Injection in Treating Paediatric B Cell-related... | The Children's Hospital of Zhejiang University School of Medicine | Early phase 1 | Recruiting | Paediatric B Cell-related Autoimmune Diseases, Autoimmune Diseases, CAR | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07283315) |
| November 24, 2025 | NCT07246096 | Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory... | Changhai Hospital | Early phase 1 | Recruiting | Autoimmune Diseases, Systemic Lupus Erythematosus, Systemic Sclerosis, Primary Sjögren Syndrome, Rheumatoid Arthritis... | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07246096) |
| September 16, 2025 | NCT07174843 | An Exploratory Study of CD19/CD22/BCMA CAR-T Cells (BZE2204) in Subjects With Relapsed or Refractory Autoimmune Diseases | Shanghai Cell Therapy Group Co.,Ltd | Early phase 1 | Recruiting | Idiopathic Inflammatory Myopathies(IIM), Immune Thrombocytopenia(ITP), Systemic Lupus Erythematosus(SLE) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07174843) |
| August 14, 2025 | NCT07122076 | GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases | Grit Biotechnology | Early phase 1 | Recruiting | Autoimmune Diseases | 10 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07122076) |
| July 31, 2025 | NCT07095075 | A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases | Nanjing Legend Biotech Co. | Early phase 1 | Recruiting | Relapsed/Refractory Autoimmune Diseases | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07095075) |
| June 27, 2025 | NCT07040917 | A Study of CAR-T Cells in Subjects With Autoimmune Diseases | Chinese PLA General Hospital | Early phase 1 | Not yet recruiting | Autoimmune Diseases | 12 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07040917) |
| April 18, 2025 | NCT06934915 | Prednisone in Adults With an Immune-Mediated Subtype of Autism Spectrum Disorder | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Autism Spectrum Disorder, Autism Spectrum Disorders, Autistic Disorder, Autism | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06934915) |
| January 27, 2025 | NCT06792799 | Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease | The Children's Hospital of Zhejiang University School of Medicine | Early phase 1 | Recruiting | Autoimmune Diseases, Systemic Lupus Erthematosus, Multi-Drug Resistant Nephrotic Syndrome, IgAN - IgA Nephropathy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06792799) |
| January 7, 2025 | NCT06762119 | A Study of CAR-T Cells in Subjects with Autoimmune Diseases | Zhejiang University | Early phase 1 | Not yet recruiting | Autoimmune Diseases | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06762119) |
| December 24, 2024 | NCT06747156 | A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases | Ruijin Hospital | Early phase 1 | Recruiting | Autoimmune Diseases | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06747156) |
| November 8, 2024 | NCT06680388 | CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases | Institute of Hematology & Blood Diseases Hospital, China | Early phase 1 | Recruiting | Autoimmune Diseases | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06680388) |
| August 12, 2024 | NCT06548607 | Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases | Nanjing Bioheng Biotech Co., Ltd. | Early phase 1 | Recruiting | SLE (Systemic Lupus), Systemic Sclerosis, ANCA Associated Vasculitis, Idiopathic Inflammatory Myopathies, Sjogren's... | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06548607) |
| May 17, 2024 | NCT06420154 | The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases | First Affiliated Hospital of Wenzhou Medical University | Early phase 1 | Not yet recruiting | Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Systemic Sclerosis, Inflammatory Myopathy, ANCA Associated... | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06420154) |
| March 19, 2024 | NCT06318533 | A Clinical Study of CAR NK Cells for the Treatment of Relapsed/Refractory B-cell Related Autoimmune Diseases | Sponsor not shown (see the record) | Early phase 1 | Recruiting | Autoimmune Diseases | 15 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06318533) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| The Children's Hospital of Zhejiang University School of Medicine | 5 |
| Chinese PLA General Hospital | 2 |
| Ruijin Hospital | 2 |
| West China Hospital | 2 |
| Zhejiang University | 2 |
| Changhai Hospital | 2 |
| Xinqiao Hospital of Chongqing | 1 |
| Nanjing Bioheng Biotech Co., Ltd. | 1 |
| [Grit Biotechnology](https://specstream.ai/data/clinical-trials/company/grit-biotechnology) | 1 |
| First Affiliated Hospital of Wenzhou Medical University | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Medical University of South Carolina | 1 |
| Shanxi Bethune Hospital | 1 |
| Shanghai Cell Therapy Group Co.,Ltd | 1 |
| Tongji Hospital | 1 |
| Nanjing Legend Biotech Co. | 1 |
| AlphaNa Bioscience Company Limited | 1 |
| Circunited BioPharma (Shenzhen) Co., Ltd. | 1 |

## By country

| Country | Trials |
| --- | --- |
| China | 24 |
| United States | 2 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Farming services in the United States](https://specstream.ai/data/businesses/farming-services/united-states)
- [Vascular medicine practices in the United States](https://specstream.ai/data/businesses/vascular-medicine-practices/united-states)
- [Iron fabricators in the United States](https://specstream.ai/data/businesses/iron-fabricators/united-states)
- [B2B secretarial companies in the United States](https://specstream.ai/data/businesses/b2b-secretarial-companies/united-states)
- [Paper mills in the United States](https://specstream.ai/data/businesses/paper-mills/united-states)
- [Coworking spaces in the United States](https://specstream.ai/data/businesses/coworking-spaces/united-states)
